Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Daiichi Sankyo
Novartis
Johnson and Johnson
McKinsey
Medtronic
Express Scripts
Fish and Richardson
Colorcon
Chubb

Generated: August 22, 2017

DrugPatentWatch Database Preview

NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE Drug Profile

« Back to Dashboard

What is the patent landscape for Norethindrone And Ethinyl Estradiol And Ferrous Fumarate, and when can generic versions of Norethindrone And Ethinyl Estradiol And Ferrous Fumarate launch?

Norethindrone And Ethinyl Estradiol And Ferrous Fumarate is a drug marketed by Lupin Ltd, Barr, Accord Hlthcare, Mylan Labs Ltd, Apil, and Amneal Pharms. and is included in seven NDAs. There is one patent protecting this drug.

The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for Tradename: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Patents:1
Applicants:6
NDAs:7
Suppliers / Packagers: see list6
Clinical Trials: see list105,791
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE at DailyMed

Expired Patents for Tradename: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apil
NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
ethinyl estradiol; norethindrone
TABLET, CHEWABLE;ORAL022573-001Dec 22, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Cerilliant
QuintilesIMS
Citi
Fuji
Mallinckrodt
Johnson and Johnson
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot